- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2023
- 155 Pages
Global
From €2275EUR$2,500USD£1,933GBP
A bone biopsy is a medical procedure that involves the removal of a small sample of bone tissue for laboratory examination. Within the context of in vitro diagnostics (IVD), bone biopsies are pivotal for diagnosing and monitoring various bone-related diseases and conditions, such as osteoporosis, infections, bone marrow disorders, and malignancies like primary bone cancer and metastatic diseases. The examination of bone biopsies typically involves histological analysis, which can determine the cellular composition of bone tissue, presence of abnormal cells, and other pathological findings that are essential for accurate diagnosis and treatment planning.
The bone biopsy market is a niche within the broader IVD market, relying on advancements in imaging technologies, biopsy devices, and pathological assessment techniques. The market caters to needs across various healthcare settings, including hospitals, diagnostic centers, and research institutions. It benefits from innovations in minimally invasive surgical techniques, which not only improve the accuracy of samples but also reduce patient discomfort and recovery times.
Among the companies operating in the bone biopsy market, notable names include Becton Dickinson (BD), Merit Medical Systems, Cook Medical, Argon Medical Devices, and Rothstein Instruments. These companies provide a range of biopsy instruments, needles, and systems designed to facilitate the procurement of bone tissue samples for diagnostic purposes. Show Less Read more